Executive TL;DR:
- CRISPR technology shows promise in selectively targeting and destroying cancer cells.
- Researchers face challenges in delivering the CRISPR enzyme to targeted cells efficiently.
- Potential treatments are still in the experimental phase, with years to decades before human trials.
The Buzz Score
The Internet’s Verdict: 70% Hyped, 30% Skeptical
Expert Opinions
Some experts express caution about the hype surrounding CRISPR technology. As one expert notes:
CRISPR is an extremely overhyped approach which found a marketing engine via popular science.
Others are more optimistic, recalling past experiences with proposed cancer cures:
I hope this finally works out. I remember almost exactly ten years ago I got excited about one of these proposed cancer cures, tried to talk about it at lunch with my coworkers, and they laughed at me for believing.
Challenges Ahead
Delivery remains a critical challenge for CRISPR therapies, with one expert pointing out that
Much like other CRISPR therapies, delivery is a critical challenge, i.e., getting the large genome-cutting enzyme to all the targeted cells efficiently.
Focus Keyword: CRISPR Cancer
